Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

Interaction of amphetamines and related compounds at the vesicular monoamine transporter.

Partilla JS, Dempsey AG, Nagpal AS, Blough BE, Baumann MH, Rothman RB.

J Pharmacol Exp Ther. 2006 Oct;319(1):237-46. Epub 2006 Jul 11.

2.

Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands.

Zheng G, Dwoskin LP, Deaciuc AG, Crooks PA.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4463-6.

3.

Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.

Miller DK, Crooks PA, Zheng G, Grinevich VP, Norrholm SD, Dwoskin LP.

J Pharmacol Exp Ther. 2004 Sep;310(3):1035-45. Epub 2004 Apr 30.

4.

The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice.

Paterson NE, Semenova S, Gasparini F, Markou A.

Psychopharmacology (Berl). 2003 May;167(3):257-64. Epub 2003 Apr 8.

PMID:
12682710
5.

Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats.

Miller DK, Harrod SB, Green TA, Wong MY, Bardo MT, Dwoskin LP.

Pharmacol Biochem Behav. 2003 Jan;74(2):279-86.

PMID:
12479946
6.

Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.

Baumann MH, Phillips JM, Ayestas MA, Ali SF, Rice KC, Rothman RB.

Ann N Y Acad Sci. 2002 Jun;965:92-108.

PMID:
12105088
7.

A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.

Dwoskin LP, Crooks PA.

Biochem Pharmacol. 2002 Jan 15;63(2):89-98. Review.

PMID:
11841781
8.

Lobeline attenuates d-methamphetamine self-administration in rats.

Harrod SB, Dwoskin LP, Crooks PA, Klebaur JE, Bardo MT.

J Pharmacol Exp Ther. 2001 Jul;298(1):172-9.

9.
12.

VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR.

Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9938-43.

13.

Pharmacology of lobeline, a nicotinic receptor ligand.

Damaj MI, Patrick GS, Creasy KR, Martin BR.

J Pharmacol Exp Ther. 1997 Jul;282(1):410-9.

15.

Sites, mechanisms, and structural characteristics of the brain's nicotine receptor.

Abood LG, Banerjee S, Kanne DB.

J Subst Abuse. 1989;1(3):259-71. Review.

PMID:
7580218
16.

Inhibition of monoamine oxidase by d-methamphetamine.

Suzuki O, Hattori H, Asano M, Oya M, Katsumata Y.

Biochem Pharmacol. 1980 Jul 15;29(14):2071-3. No abstract available.

PMID:
6773528
17.

Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

Reavill C, Walther B, Stolerman IP, Testa B.

Neuropharmacology. 1990 Jul;29(7):619-24.

PMID:
2385332
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk